Exam 3: Ch. 16-20 Flashcards
main function of breasts
milk production
two main types of breast tissue
glandular tissue-lobules and ducts
stromal tissue-supporting tissue
stromal tissue
fatty and fibrous connective tissue that gives breasts size, shape, and support
structure of breast
20 lobes of glandular tissue, each made of cluster of milk producing lobules which are connected to the nipple by branching ducts
suspensory ligaments
bands of fibrous tissue extending from skin to connective tissue covering chest wall muscles
where do lymph vessels in the breast lead to?
axillary nodes (near armpit), if cancer cells reach here the nodes swell and the cancer is more likely to spread
what happens to breasts during puberty?
they enlarge in response to estrogen and progesterone
- glandular and fibrous tissue proliferates
- adipose tissue accumulates
what happens to breasts during menstrual cycle?
responds to hormonal stimulation, they experience hyperplasia (growth) and involution (shrinking) in a cycle
what happens to breasts during pregnancy?
the glandular and ductal tissues are hypertrophic (cell size increases)
what happens to breasts after menopause?
sex hormone levels decline, so the breasts gradually decrease in size
clinical breast exam
-inspection, palpation, examination of axillary tissues
-first w/ arms at sides
-next w/ arms elevated, then lowered
last w/ hands on hips
palpation of breasts should begin where?
periphery of breast and in clockwise direction
mammogram
x-ray examination to identify lesions that can’t be detected on a clinical examination
baseline age of first mammogram?
35-40, or earlier if family history is present
when should you get a mammogram annually?
at age 40 and after
a mammogram is most useful for what population?
postmenopausal women, because their breasts contain more fat and less glandular tissue
-a tumor will contrast more sharply with the fatty tissue (less dense)
more dense masses show as what color on a mammogram?
white
less dense masses show as what color on a mammogram?
dark
cysts and benign tumors are well or poorly circumscribed?
well circumscribed, usually even borders and differ sharply from cells around them
malignant tumors usually are what?
poorly circumscribed, irregular borders and fine flecks of calcium
why may MRI be better than a mammogram?
it detects small carcinomas better and non-significant breast changes
accessory breast/nipple
common sites include armpit or lower chest below and medial to normal breasts-when an extra nipple forms
unequal development
fully developed breasts are usually not exactly the same, one usually fails to develop as much
breast hypertrophy
puberty; one or both breasts over-respond to hormonal stimulation and results from overgrowth of fibrous tissue
gynecomastia
ductal and fibrous tissue of an adolescent male proliferates from a temporary imbalance of female and male hormones at puberty (formation of small female breasts)
benign cystic change
very common, also called fibrocystic disease
-where focal areas of proliferation of glandular and fibrous tissue are present our to irregular cyclic response to hormones
what diagnoses a benign cystic change
ultrasound, distinguishes cystic from solid mass
treatment for benign cystic change
aspiration of cyst (removal of fluid via needle)
surgical excision
fibroadenoma
benign, well circumscribed tumor of the fibrous and glandular tissue that is common in young women and surgically removed
risk factors for breast carcinoma
family history (mother or sister), hormonal factors, first pregnancy after age 30, early menarche (1st period), late menopause, occurs in 1/10 women
progestin
synthetic compound with progesterone activity, often given with estrogen in combined hormone therapy
combined hormone therapy
treats menopausal symptoms, but increases density of breast tissue therefore complicating mammograms
long term estrogen+progestin use increases risk of breast carcinoma by what percent?
8%
long term use of just estrogen increases risk of breast carcinoma by what percent?
1%
mutant BRCA1 gene
increases breast cancer (80%) and ovarian carcinoma (20-40%) risk, large gene with many mutations
mutant BRCA2 gene
increases breast cancer (80%) and ovarian carcinoma (10-20%)
clinical manifestations of breast carcinoma
- lump in breast
- nipple or skin retraction
- skin edema (orange peel sign, skin around nipple looks like an orange peel)
3 classification criteria of breast carcinoma
- site of origin (ductal, lobular, in situ)
- presence or absence of invasion
- degree of differentiation of tumor cells (well-normal tissue, poor-bizarre cells)
ductal carcinoma accounts for how many breast carcinomas?
90%
in situ cancer
non-invasive, can become invasive
mammogram can identify carcinoma up to how long before a manual breast exam?
2 years
modified radical mastectomy
aka total mastectomy with axillary lymph node dissection
- resecting (removing) entire breast, axillary tissue with lymph nodes
- can be followed by breast reconstruction
partial mastectomy
removing the part of the breast with the tumor
-axillary nodes removed, radiation follows to make sure all carcinoma is gone
lumpectomy
removing the tumor and a small amount of adjacent breast tissue, and the axillary nodes followed by radiation
adjuvant therapy
eradicate any tumor cells that may have spread beyond the breast
- anticancer drugs (adjuvant chemo)
- anti estrogen drugs (adjuvant hormonal therapy)
in adjuvant therapy, part of the tumor is surgically tested to:
- detect presence of estrogen and progesterone receptors
2. detect amplification of HER-2 gene that speeds growth rate of tumor cells (if positive, prognosis is worse)
hormone receptor status
if estrogen receptors (ER) and progesterone receptors (PR) are present in breast carcinoma, prognosis is more favorable
-treatment used is anti estrogen adjuvant therapy
recurrent and metastatic carcinoma
- can appear many years after original tumor
- no longer curable and treatment is to control growth and improve quality of life
treatment for recurrent carcinoma
tumor is hormone receptor positive:
-use anti estrogen drugs in premenopausal
-use aromatase inhibitor drugs in postmenopausal
tumor is hormone receptor negative:
-hormonal manipulation
radiation controls deposits in bone
breast sarcoma
rare, arises from fibrous tissue or blood vessels
- large and bulky
- may metastasize widely
- treatment is surgical resection (removal)
vaginitis
common, causes vaginal discharge, itching, and irritation
cervicitis
mild chronic inflammation, common in women that have had children
-can spread to infect tubes and adjacent tissues, causing pelvic inflammatory disease
salpingitis
tubal infection
pelvic inflammatory disease (PID)
inflammation of fallopian tubes, and sometimes the ovaries
-manifests as lower abdominal pain and tenderness, fever, and can cause tubal scarring
condylomas
venereal warts in genital tract
-tumor like overgrowths of squamous epithelium transmitted by sexual contact, benign
common locations of condylomas
mucosa of cervix and vagina, vaginal opening, anus
treatment of condylomas
aims to destroy the lesions
- freezing
- surgical excision
- strong chemical
endometriosis
deposits of endometrial tissue outside normal location
- uterine wall, ovary, elsewhere in pelvis, appendix, rectum
- the tissue undergoes cyclic desquamation (shedding) causing intense cramping, can cause scarring
what diagnoses endometriosis
laparoscopy-visualization of ectopic deposits followed by removing or destroying the deposits
treatment of endometriosis
- synthetic hormones-suppress menstrual cycle
- oral contraceptives-suppress ovulation, retarding progression of endometriosis
- drugs that suppress output of gonadotropin-declin in ovarian function, deposits of endometriosis regress
cervical polyps
benign, arise from cervix and usually small
-need to be surgically removed, erosion of the tip can cause bleeding
cervical dysplasia
abnormal growth and maturation of cervical squamous epithelium
-mild and severe dysplasia
mild cervical dysplasia
results from cervical dysplasia and regresses spontaneously
severe cervical dysplasia
does not regress and can progress to in situ carcinoma, which then may progress to invasive carcinoma
cervical intraepithelial neoplasia
different stages in a progressive spectrum of epithelial abnormalities with 3 grades
Grade I: mild
Grade II: moderate
Grade III: severe
HPV genital tract infection
80+ strains, 8 are carcinogenic
- common in young sexually active women
- 90% of infections resolve themselves in 6-12 months
diagnosis of HPV
pap smear with inconclusive results, HPV test given
HPV vaccine
- 1st vaccine: 2006, protects types 6, 11, 16, and 18
- 2nd vaccine: 2009, protects types 16 and 18
types 6 and 11 are responsible for what?
90% of genital tract condyloma
types 16 and 18 are responsible for what?
70% of cervical dysplasia and carcinoma
cervical dysplasia and carcinoma
develops in cells between squamous epithelium at exterior cervix and columnar epithelium lining cervical canal (between exterior cervix and cervical canal)
treatment for cervical dysplasia and carcinoma
dysplasia and in situ: freezing, surgical excision, hysterectomy (produce excellent results)
invasive carcinoma: radiation, radical hysterectomy (les satisfactory results)
radical hysterectomy
resection (removal) of uterus, fallopian tubes, ovaries, and adjacent tissues
benign endometrial hyperplasia
irregular uterine bleeding
benign endometrial polyps
common, and may cause bleeding if tip is eroded
endometrial adenocarcinoma
prolonged endometrial stimulation by estrogen use, has irregular uterine bleeding or postmenopausal bleeding
uterine myoma
benign smooth muscle tumor from uterine wall
- 30% women over 30 have them
- cause irregular/heavy uterine bleeding
- pressure on bladder and rectum
dysfunctional uterine bleeding
follicle fails to mature and no corpus luteum is formed, subjecting uterus to continuous estrogen stimulation so it sheds and bleeds in an irregular fashion instead of all at once
first part of menstrual cycle
endometrial glands and stroma proliferate under influence of estrogen
mid-cycle of menstrual cycle
ovulation-follicle discharges egg, become corpus luteum that produces estrogen and progesterone
-endometrium undergoes secretory phase, prepares to receive fertilized ovum
what happens if no pregnancy occurs
corpus luteum degrades, estrogen-progesterone levels fall, and secretory endometrium is shed with blood and a new cycle begins
dysmenorrhea
primary and secondary-painful periods, typically involving abdominal cramps
primary dysmenorrhea
most common, periods painless for first two years after menarche, then prostaglandins are synthesized under influence of progesterone and released from endometrium and cause pain
primary dysmenorrhea pain
crampy lower abdominal pain that begins just before menstruation, and lasts for 1-2 days after onset of menstrual flow
treatment: prostaglandin inhibitors and oral contraceptives
secondary dysmenorrhea
from diseases of pelvic organs, such as endometriosis
-treatment: correct the underlying disease
ovarian cysts
arise from ovarian follicles or corpora lute that have failed to regress normally and converted to fluid-filled cysts
functional cysts
follicle and corpus luteum cysts from deranged maturation and involution (shrink), regress spontaneously, don’t become large
endometrial cysts
endometrial deposits in ovary filled with old blood and debris
benign cystic teratoma
- dermoid cyst
- come from unfertilized ova that undergo neoplastic change
- contain skin, hair, teeth, parts of GI tract, other tissues
malignant teratoma
very rare, usually benign
ovarian tumors
resemble epithelium found in other parts of genital tract
serous tumor
resembles cells lining fallopian tubes
- cystadenoma
- cystadenocarcinoma
cystadenoma
benign, cystic serous tumor
cystadenocarcinoma
neoplastic epithelium may extend on the surface of tumor and break off, implanting in other places
mucinous tumor
resembles mucus-secreting tumor of endocervix
- mucinous cystadenoma
- mucinous cystadenocarcinoma
endometrioid tumor
resembled endometrial tissue (endometrioid carcinoma)
fibroma
from fibrous connective tissue cells of ovary
granulosa
theca cell tumor
- ovarian, produces estrogen
- from granulose cells (estrogen producing cells) that line follicle
- induces endometrial stimulation
male hormone-producing ovarian tumors
induces masculinization in a female
vulvar dystrophy
- irregular white patches (leukoplakia) on vulvar skin
- intense itching
- can progress to carcinoma, local treatment is usually effective
carcinoma of the vulva
- in both pre and post menopausal women
- usually w/ preexisting vulvar dystrophy
- treated by vulvectomy and excision of inguinal lymph nodes
toxic shock syndrome
most common in women that use high absorbency tampons
- toxin produced by staphylococci
- menstrual blood and secretions are a good culture medium
how do tampons cause toxic shock syndrome
they slow drainage of menstruate, may cause superficial erosions on vaginal mucosa allowing toxin to be absorbed
clinical manifestations of TSS
fever, vomiting, diarrhea, muscle pains, sunburn-like rash followed by flaking and peeling
treatment of TSS
general supportive measures, discontinue tampon use, antibiotics eradicate staphylococci but do not shorten course